References in periodicals archive ?
This compares to the Company's previous guidance range of $1,125.
Elanex noted that questions have been asked as to how NESP compares to Epoetin Omega in serum concentration, potency, and circulation time.
This compares to net earnings applicable to common shares for the third quarter of last year of $90.
Wednesday announced a third quarter loss of $(2,704,000) or (58 cents) per share, which compares to the restated earnings of $183,000 or 4 cents per share for the like period last year.